Lehman & Derafelo Financial Resources LLC Intra Cellular Therapies, Inc. Transaction History
Lehman & Derafelo Financial Resources LLC
- $337 Million
- Q4 2022
A detailed history of Lehman & Derafelo Financial Resources LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Lehman & Derafelo Financial Resources LLC holds 20,000 shares of ITCI stock, worth $1.73 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$1.73 Million% of portfolio
0.18%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
378Shares Held
84.7MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$834 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$547 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$458 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$333 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$264 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.17B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...